Chapman William C, Barbas Andrew S, D'Alessandro Anthony M, Vianna Rodrigo, Kubal Chandrashekhar A, Abt Peter, Sonnenday Christopher, Barth Rolf, Alvarez-Casas Josue, Yersiz Hasan, Eckhoff Devin, Cannon Robert, Genyk Yuri, Sher Linda, Singer Andrew, Feng Sandy, Roll Garrett, Cohen Ari, Doyle Maria B, Sudan Debra L, Al-Adra David, Khan Adeel, Subramanian Vijay, Abraham Nader, Olthoff Kim, Tekin Akin, Berg Lynn, Coussios Constantin, Morris Chris, Randle Lucy, Friend Peter, Knechtle Stuart J
Department of Surgery, School of Medicine, Washington University, St. Louis.
Department of Surgery, Duke University School of Medicine.
Ann Surg. 2023 Nov 1;278(5):e912-e921. doi: 10.1097/SLA.0000000000005934. Epub 2023 Jun 26.
To compare conventional low-temperature storage of transplant donor livers [static cold storage (SCS)] with storage of the organs at physiological body temperature [normothermic machine perfusion (NMP)].
The high success rate of liver transplantation is constrained by the shortage of transplantable organs (eg, waiting list mortality >20% in many centers). NMP maintains the liver in a functioning state to improve preservation quality and enable testing of the organ before transplantation. This is of greatest potential value with organs from brain-dead donor organs (DBD) with risk factors (age and comorbidities), and those from donors declared dead by cardiovascular criteria (donation after circulatory death).
Three hundred eighty-three donor organs were randomized by 15 US liver transplant centers to undergo NMP (n = 192) or SCS (n = 191). Two hundred sixty-six donor livers proceeded to transplantation (NMP: n = 136; SCS: n = 130). The primary endpoint of the study was "early allograft dysfunction" (EAD), a marker of early posttransplant liver injury and function.
The difference in the incidence of EAD did not achieve significance, with 20.6% (NMP) versus 23.7% (SCS). Using exploratory, "as-treated" rather than "intent-to-treat," subgroup analyses, there was a greater effect size in donation after circulatory death donor livers (22.8% NMP vs 44.6% SCS) and in organs in the highest risk quartile by donor risk (19.2% NMP vs 33.3% SCS). The incidence of acute cardiovascular decompensation at organ reperfusion, "postreperfusion syndrome," as a secondary outcome was reduced in the NMP arm (5.9% vs 14.6%).
NMP did not lower EAD, perhaps related to the inclusion of lower-risk liver donors, as higher-risk donor livers seemed to benefit more. The technology is safe in standard organ recovery and seems to have the greatest benefit for marginal donors.
比较移植供肝的传统低温保存法[静态冷藏(SCS)]与在生理体温下保存器官[常温机器灌注(NMP)]。
肝移植的高成功率受到可移植器官短缺的限制(例如,许多中心等待名单上的死亡率>20%)。NMP可使肝脏维持在功能状态,以提高保存质量,并能在移植前对器官进行检测。对于有危险因素(年龄和合并症)的脑死亡供体器官(DBD)以及那些按心血管标准判定死亡的供体(循环死亡后捐赠)的器官,这具有最大的潜在价值。
美国15个肝移植中心将383个供体器官随机分组,分别进行NMP(n = 192)或SCS(n = 191)。266个供体肝脏进行了移植(NMP组:n = 136;SCS组:n = 130)。该研究的主要终点是“早期移植肝功能障碍”(EAD),这是移植后早期肝损伤和功能的一个指标。
EAD发生率的差异未达到显著水平,NMP组为20.6%,SCS组为23.7%。采用探索性的“实际治疗”而非“意向性治疗”亚组分析,在循环死亡后捐赠的供体肝脏(NMP组为22.8%,SCS组为44.6%)以及供体风险处于最高四分位数的器官(NMP组为19.2%,SCS组为33.3%)中,效应量更大。作为次要结果,NMP组器官再灌注时急性心血管失代偿(“再灌注综合征”)的发生率降低(5.9%对14.6%)。
NMP并未降低EAD,这可能与纳入了低风险肝脏供体有关,因为高风险供体肝脏似乎受益更多。该技术在标准器官获取过程中是安全的,并且似乎对边缘供体有最大益处。